Home > Products > BAFF & IL17
> Human Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-IgG)
Human Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H197)
Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-BAFF and anti-IL17 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can neutralize both BAFF and IL- 17 simultaneously. It is designed for the research of Lupus Nephritis (LN); Systemic Lupus Erythematosus (SLE); Rheumatoid Arthritis (RA); Psoriasis (Ps); Ankylosing Spondylitis (AS); Psoriatic Arthritis (PA) primary Sjögren's Syndrome (pSS); Multiple Myeloma (MM) therapy.
There are currently no customer reviews or questions for Human Anti-BAFF x Anti-IL17 Bispecific Antibody (IgG-IgG) (BSIG-H197). Click the button below to contact us or submit your feedback about this product.